Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
NCT04857983
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
62
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
DRUG:
Memantine
DRUG:
Placebo
Sponsor
University of California, San Diego